Sibei Tao

1.6k total citations · 2 hit papers
22 papers, 1.0k citations indexed

About

Sibei Tao is a scholar working on Molecular Biology, Nephrology and Surgery. According to data from OpenAlex, Sibei Tao has authored 22 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Nephrology and 7 papers in Surgery. Recurrent topics in Sibei Tao's work include Muscle and Compartmental Disorders (3 papers), Heme Oxygenase-1 and Carbon Monoxide (3 papers) and Acute Kidney Injury Research (3 papers). Sibei Tao is often cited by papers focused on Muscle and Compartmental Disorders (3 papers), Heme Oxygenase-1 and Carbon Monoxide (3 papers) and Acute Kidney Injury Research (3 papers). Sibei Tao collaborates with scholars based in China, United States and United Kingdom. Sibei Tao's co-authors include Fan Guo, Ping Fu, Rongshuang Huang, Ping Fu, Qian Ren, Liang Ma, Liang Ma, Letian Yang, Xiaoxi Zeng and Jing Liu and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Sibei Tao

22 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Flavonoid fisetin alleviates kidney inflammation and apoptosis via inhibiting Src-mediated NF-κB p65 and MAPK signaling pathways in septic AKI mice

2019 305 citations Qian Ren, Fan Guo et al. Biomedicine & Pharmacotherapy profile →
Inhibition of ACSS2-mediated histone crotonylation alleviates kidney fibrosis via IL-1β-dependent macrophage activation and tubular cell senescence

2024 52 citations Lingzhi Li, Ting Xiang et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sibei Tao China	17	424	344	114	103	100	22	1.0k
Yuh‐Mou Sue Taiwan	19	300 0.7×	223 0.6×	89 0.8×	59 0.6×	115 1.1×	69	1.5k
Orestes Foresto‐Neto Brazil	16	492 1.2×	429 1.2×	50 0.4×	226 2.2×	68 0.7×	24	1.1k
Yu Ah Hong South Korea	18	415 1.0×	459 1.3×	44 0.4×	80 0.8×	232 2.3×	83	1.4k
Suzanne Heemskerk Netherlands	19	287 0.7×	439 1.3×	61 0.5×	96 0.9×	69 0.7×	28	1.3k
Lihua Wang China	19	233 0.5×	269 0.8×	38 0.3×	48 0.5×	129 1.3×	70	983
Jianying Niu China	18	215 0.5×	268 0.8×	29 0.3×	104 1.0×	80 0.8×	54	907
Kam Wa Chan Hong Kong	15	198 0.5×	138 0.4×	89 0.8×	76 0.7×	47 0.5×	47	1.1k
Simona Granata Italy	23	634 1.5×	447 1.3×	30 0.3×	144 1.4×	121 1.2×	62	1.6k
Ciprian Rezuș Romania	17	302 0.7×	103 0.3×	28 0.2×	102 1.0×	118 1.2×	84	1.1k
Jiao Chen China	18	524 1.2×	114 0.3×	38 0.3×	109 1.1×	91 0.9×	62	1.3k

Countries citing papers authored by Sibei Tao

Since Specialization

Citations

This map shows the geographic impact of Sibei Tao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sibei Tao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sibei Tao more than expected).

Fields of papers citing papers by Sibei Tao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sibei Tao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sibei Tao. The network helps show where Sibei Tao may publish in the future.

Co-authorship network of co-authors of Sibei Tao

This figure shows the co-authorship network connecting the top 25 collaborators of Sibei Tao. A scholar is included among the top collaborators of Sibei Tao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sibei Tao. Sibei Tao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Lingzhi, Ting Xiang, Jingjing Guo, et al.. (2024). Inhibition of ACSS2-mediated histone crotonylation alleviates kidney fibrosis via IL-1β-dependent macrophage activation and tubular cell senescence. Nature Communications. 15(1). 3200–3200. 52 indexed citations breakdown →

Huang, Rongshuang, Min Shi, Fan Guo, et al.. (2023). Novel aspect of neprilysin in kidney fibrosis via ACSL4‐mediated ferroptosis of tubular epithelial cells. SHILAP Revista de lepidopterología. 4(4). e330–e330. 19 indexed citations

Tao, Sibei, Lina Yang, Chenzhou Wu, et al.. (2022). Gambogenic acid alleviates kidney fibrosis via epigenetic inhibition of EZH2 to regulate Smad7-dependent mechanism. Phytomedicine. 106. 154390–154390. 17 indexed citations

Yang, Letian, Bo Wang, Fan Guo, et al.. (2022). FFAR4 improves the senescence of tubular epithelial cells by AMPK/SirT3 signaling in acute kidney injury. Signal Transduction and Targeted Therapy. 7(1). 384–384. 76 indexed citations

Li, Lingzhi, Qian Ren, Han Feng, et al.. (2022). Understanding the Gut-Kidney Axis in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: An Analysis of Gut Microbiota Composition. Frontiers in Pharmacology. 13. 783679–783679. 15 indexed citations

Tao, Sibei, et al.. (2022). Discovery of indol-6-yl-pyrrolo[2,3-c]pyridin-7-one derivatives as bromodomain-containing protein 4 (BRD4) inhibitors for the treatment of kidney fibrosis. European Journal of Medicinal Chemistry. 231. 114153–114153. 13 indexed citations

Li, Lingzhi, Sibei Tao, Fan Guo, et al.. (2021). Genetic and pharmacological inhibition of fatty acid-binding protein 4 alleviated inflammation and early fibrosis after toxin induced kidney injury. International Immunopharmacology. 96. 107760–107760. 16 indexed citations

Tao, Sibei, et al.. (2021). Natural flavonol fisetin attenuated hyperuricemic nephropathy via inhibiting IL-6/JAK2/STAT3 and TGF-β/SMAD3 signaling. Phytomedicine. 87. 153552–153552. 98 indexed citations

Wei, Tiantian, Letian Yang, Fan Guo, et al.. (2020). Activation of GPR120 in podocytes ameliorates kidney fibrosis and inflammation in diabetic nephropathy. Acta Pharmacologica Sinica. 42(2). 252–263. 39 indexed citations

10.

Pan, Jing, Chunle Zhang, Min Shi, et al.. (2020). Ethanol extract of Liriodendron chinense (Hemsl.) Sarg barks attenuates hyperuricemic nephropathy by inhibiting renal fibrosis and inflammation in mice. Journal of Ethnopharmacology. 264. 113278–113278. 36 indexed citations

11.

Tao, Sibei, Fan Guo, Qian Ren, et al.. (2020). Activation of aryl hydrocarbon receptor by 6‐formylindolo[3,2‐b]carbazole alleviated acute kidney injury by repressing inflammation and apoptosis. Journal of Cellular and Molecular Medicine. 25(2). 1035–1047. 20 indexed citations

12.

Tao, Sibei, et al.. (2019). Roles of short-chain fatty acids in kidney diseases. Chinese Medical Journal. 132(10). 1228–1232. 38 indexed citations

13.

Tao, Sibei, Xiaoxi Zeng, Jing Liu, & Ping Fu. (2019). Socioeconomic status and mortality among dialysis patients: a systematic review and meta-analysis. International Urology and Nephrology. 51(3). 509–518. 21 indexed citations

14.

Liu, Jing, Fan Guo, Xinrui Li, et al.. (2019). 2-methylquinazoline derivative F7 as a potent and selective HDAC6 inhibitor protected against rhabdomyolysis-induced acute kidney injury. PLoS ONE. 14(10). e0224158–e0224158. 10 indexed citations

15.

Ren, Qian, Fan Guo, Sibei Tao, et al.. (2019). Flavonoid fisetin alleviates kidney inflammation and apoptosis via inhibiting Src-mediated NF-κB p65 and MAPK signaling pathways in septic AKI mice. Biomedicine & Pharmacotherapy. 122. 109772–109772. 305 indexed citations breakdown →

16.

Tao, Sibei, Wen Zheng, Yuan Liu, et al.. (2019). Analysis of serum metabolomics among biopsy-proven diabetic nephropathy, type 2 diabetes mellitus and healthy controls. RSC Advances. 9(33). 18713–18719. 7 indexed citations

17.

Tao, Sibei, Siying Tao, Yiming Cheng, et al.. (2018). Effects of probiotic supplements on the progression of chronic kidney disease: A meta‐analysis. Nephrology. 24(11). 1122–1130. 28 indexed citations

18.

Tao, Siying, Yan Zhu, He Yuan, et al.. (2018). Efficacy of fluorides and CPP-ACP vs fluorides monotherapy on early caries lesions: A systematic review and meta-analysis. PLoS ONE. 13(4). e0196660–e0196660. 42 indexed citations

19.

Zeng, Xiaoxi, Jing Liu, Sibei Tao, et al.. (2018). Associations between socioeconomic status and chronic kidney disease: a meta-analysis. Journal of Epidemiology & Community Health. 72(4). 270–279. 89 indexed citations

20.

Tao, Siying, Lan Li, He Yuan, et al.. (2017). Erbium Laser Technology vs Traditional Drilling for Caries Removal: A Systematic Review with Meta-Analysis. Journal of Evidence Based Dental Practice. 17(4). 324–334. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact